We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BITGF market cap is 1.17B. The company's latest EPS is SEK 3.3497 and P/E is 4.37.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 910.9M | 1.1B | 1.09B | 1.23B | 1.57B |
| Operating Income | 157.22M | 205.71M | 186M | 255M | 292M |
| Net Income | 167.63M | 186.82M | 175.33M | 205M | 268M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 1B | 1.34B | 1.43B | 1.99B | 2.34B |
| Total Liabilities | 301.02M | 460.18M | 444.4M | 621M | 702M |
| Total Equity | 702.18M | 875.5M | 990.04M | 1.37B | 1.64B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 155.01M | 211.81M | 279.05M | 353M | 340M |
| Investing | -178.41M | -85.68M | -61.32M | -341M | -84M |
| Financing | 19.34M | -119.21M | -22.72M | -82M | -133M |
| Market Cap | 1.17B |
| Price to Earnings Ratio | 4.37 |
| Price to Sales Ratio | 0.75 |
| Price to Cash Ratio | 2.65 |
| Price to Book Ratio | 0.72 |
| Dividend Yield | - |
| Shares Outstanding | 80.01M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 300 |
| 52 Week Change | 46.30% |
| 52 Week High | 16.87 |
| 52 Week Low | 8.00 |
| Spread (Intraday) | 1.12 (6.47%) |
| Company Name | Biotage AB (PK) |
| Address |
vimpelgatan 5 uppsala SE-751 03 |
| Website | https://www.biotage.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
